Evidence map›Paper›PMID 27098517›Full record

ArticleJournal of neurovirology2016

Innate defense mechanisms against HSV-1 infection in the target tissues, skin and brain.

Yael Tsalenchuck, Israel Steiner, Amos Panet

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neurovirology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Human Nasal and Lung Tissues InfectedJournal of virology · 2021
    Article
  4. Article
  5. Article
  6. Different effects of the immunostimulatory drug Stimforte on infections of hepatitis C virus and herpes simplex virus type 1.Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2017
    Article
  7. Innate Immune Mechanisms and Herpes Simplex Virus Infection and Disease.Advances in anatomy, embryology, and cell biology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Yael TsalenchuckDepartment of Biochemistry, IMRIC, The Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Israel SteinerDepartment of Neurology, Rabin Medical Center, Campus Beilinson, Petach Tikva, Israel.
Amos PanetDepartment of Biochemistry, IMRIC, The Hebrew University-Hadassah Medical School, Jerusalem, Israel. amospa@ekmd.huji.ac.il.
Hebrew University of Jerusalem · ILRabin Medical Center · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Herpes simplex virus type 1 (HSV-1) initiates productive infection in mucocutaneous tissues to cause cold sores and establishes latent infection in the trigeminal ganglia. Under certain circumstances, HSV-1 may cause encephalitis. Here, we compared host innate defenses against HSV-1 in the two clinically relevant tissues, skin and brain, using a unique ex vivo system of organ culture. Upon HSV-1 infection and spread, apoptosis induction was observed in the skin, but not in brain tissues. While the two tissues elicited interferon (IFN-β) response upon HSV1 infection, IFN induction was more robust in the skin compared to the brain. Moreover, antiviral response to exogenous IFNβ treatment was much stronger in the skin compared to brain tissues. This observation was not related to the availability of the IFN receptor on cells' surface. Taken together, our study demonstrates differential innate antiviral responses to HSV-1 infection that may be exploited in future development of selective and tissue-specific anti-viral treatments.

Indexed as

Immunity, InnateAcyclovirAnimalsAntiviral AgentsBrainGene ExpressionGenes, ReporterGreen Fluorescent ProteinsHerpes SimplexHerpesvirus 1, HumanHost-Pathogen InteractionsHumansInterferon-betaLac OperonMiceMyxovirus Resistance ProteinsAcyclovirAntiviral AgentsGreen Fluorescent ProteinsIFNAR1 protein, humanInterferon-betaMX1 protein, humanMyxovirus Resistance ProteinsReceptor, Interferon alpha-betaHerpes simplex virus type 1InterferonsPeripheral sensory ganglia

Identifiers

PMID27098517
OpenAlexW2339662699

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.